Mesenchymal Stem Cells Attenuate Acute Liver Failure by Promoting Expansion of Regulatory T Cells in an Indoleamine 2,3-Dioxygenase-Dependent Manner

Miloradovic, Dragana; Miloradovic, Dragica; Jankovic, Marina Gazdic; Markovic, Bojana Simovic; Harrell, C. Randall; Fellabaum, Crissy; Arsenijevic, Nebojsa; Lukic, Aleksandra; Volarevic, Vladislav

doi:10.2478/sjecr-2018-0043

Abstract

The influence of mesenchymal stem cells (MSCs) on the phenotype and function of CD4+CD49b+FoxP3- regulatory cells has not been elucidated. We used Concanavalin A (ConA) - and α-galactosylceramide (α-GalCer)-induced acute liver injury to estimate the effects of MSCs on liver-infiltrating CD4+CD49b+FoxP3-regulatory cells. MSCs significantly reduced ConA- and α-GalCer-mediated liver injury in C57BL/6 mice, as demonstrated by biochemical tests, reduced influx of inflammatory CD4+ T cells, and increased presence of CD4+CD49b+FoxP3- regulatory cells in the injured livers. The number of CD4+CD49b+FoxP3-regulatory cells was also significantly increased in α-GalCer-treated mice that received MSC-derived conditioned medium (MSC-CM). The presence of 1-methyltryptophan, a specific inhibitor of indoleamine 2,3-dioxygenase (IDO), in MSC-CM completely abrogated the hepatoprotective eff ect of MSCs and significantly decreased the total number of liver-infiltrated CD4+CD49b+FoxP3- regulatory cells, indicating the crucial importance of MSC-derived IDO for the expansion of CD4+CD49b+FoxP3- regulatory cells and the consequent MSC-dependent attenuation of acute liver injury.

References

1. Zhou Y, Dai W, Lin C, Wang F, He L, Shen M, Chen P, Wang C, Lu J, Xu L, XuX,Guo C. Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm. 2013;2013:706156.10.1155/2013/706156380645524198446
Search in Google Scholar Back to article
2. Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. ClinExpImmunol. 1982;50:17-24.
Search in Google Scholar Back to article
3. Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M. Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells. 2011 (1):5-10.10.1002/stem.556305941021280154
Search in Google Scholar Back to article
4. Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74:2345-2360.10.1007/s00018-017-2473-528214990
Search in Google Scholar Back to article
5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC,Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-9.10.1038/nature0087012077603
Search in Google Scholar Back to article
6. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111:1327-33.10.1182/blood-2007-02-07499717951526
Search in Google Scholar Back to article
7. Nikolic A, SimovicMarkovic B, Gazdic M, Randall Harrell C, FellabaumC,Jovicic N, Djonov V, Arsenijevic N, L Lukic M, Stojkovic M, VolarevicV.Intraperito-neal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Biomed Pharmacother. 2018;100:426-432.10.1016/j.biopha.2018.02.06029471245
Search in Google Scholar Back to article
8. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005;175:1540-50.10.4049/jimmunol.175.3.154016034092
Search in Google Scholar Back to article
9. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90:196-203.10.1172/JCI1158364430811634608
Search in Google Scholar Back to article
10. Volarevic V, Misirkic M, Vucicevic L, Paunovic V, SimovicMarkovicB,Stojanovic M, Milovanovic M, Jakovljevic V, Micic D, Arsenijevic N, Trajkovic V, Lukic ML. Metformin aggravates immune-mediated liver injury in mice. Arch Toxicol. 2015;89:437-50.10.1007/s00204-014-1263-124770553
Search in Google Scholar Back to article
11. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, MitrovicS,Pejnovic N, Arsenijevic N, Lukic ML. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol. 2012;56:26-33.10.1016/j.jhep.2011.03.02221703183
Search in Google Scholar Back to article
12. Gazdic M, SimovicMarkovic B, Vucicevic L, Nikolic T, Djonov V, ArsenijevicN,Trajkovic V, Lukic ML, Volarevic V. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. J Tissue EngRegen Med. 2018;12:e1173-e1185.10.1002/term.245228488390
Search in Google Scholar Back to article
13. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005;175:1540-50.10.4049/jimmunol.175.3.154016034092
Search in Google Scholar Back to article
14. Milosavljevic N, Gazdic M, SimovicMarkovic B, Arsenijevic A, NurkovicJ,Dolicanin Z, Djonov V, Lukic ML, Volarevic V. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23:1040-1050.10.1002/lt.2478428481005
Search in Google Scholar Back to article
15. Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR,Fellabaum C, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018;24:687-702.10.1002/lt.2504929500914
Search in Google Scholar Back to article
16. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology. 2012;55:1954-64.10.1002/hep.2554222213244
Search in Google Scholar Back to article
17. Volarevic V, Markovic BS, Bojic S, Stojanovic M, Nilsson U, Leffler H, Besra GS, Arsenijevic N, Paunovic V, Trajkovic V, Lukic ML. Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury. Eur J Immunol. 2015;45:531-43.10.1002/eji.20144484925359399
Search in Google Scholar Back to article
18. Linero I, Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One. 2014;9:e107001.10.1371/journal.pone.0107001415784425198551
Search in Google Scholar Back to article
19. Yang SH, Park MJ, Yoon IH, Kim SY, Hong SH, Shin JY, Nam HY, Kim YH, Kim B, Park CG. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. ExpMol Med. 2009;41:315-24.10.3858/emm.2009.41.5.035270198019307751
Search in Google Scholar Back to article
20. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-22.10.1182/blood-2004-04-155915494428
Search in Google Scholar Back to article
21. Milosavljevic N, Gazdic M, SimovicMarkovic B, Arsenijevic A, NurkovicJ,Dolicanin Z, Jovicic N, Jeftic I, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Mes-enchymal stem cells attenuate liver fibrosis by suppressing Th17 cells – an experimental study. Transpl Int. 2018;31:102-11510.1111/tri.1302328805262
Search in Google Scholar Back to article
22. Lim JY, Im KI, Lee ES, Kim N, Nam YS, Jeon YW, Cho SG. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016;6:26851.10.1038/srep26851488799827246365
Search in Google Scholar Back to article
23. Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells. 2014;32:2818-23.10.1002/stem.181825154380
Search in Google Scholar Back to article
24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61.10.1126/science.107949012522256
Search in Google Scholar Back to article
25. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737-42.10.1038/396149338786
Search in Google Scholar Back to article
26. Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nature medicine. 2013; 19:739–46.10.1038/nm.317923624599
Search in Google Scholar Back to article
27. Ahangarani RR, Janssens W, VanderElst L, Carlier V, VandenDriessche T, Chuah M, Weynand B, Vanoirbeek JA, Jacquemin M, Saint-Remy JM. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness. J Immunol. 2009;183:8232-43.10.4049/jimmunol.090177720007587
Search in Google Scholar Back to article
28. Xu L, Yin W, Sun R, Wei H, Tian Z. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. ProcNatlAcadSci U S A. 2013;110:16993-8.10.1073/pnas.1306437110380106224089450
Search in Google Scholar Back to article
29. Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, Gorin NC, Fouillard L. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol. 2008;253:16-22.10.1016/j.cellimm.2008.06.00218639869
Search in Google Scholar Back to article
30. Carpentier A, Conti F, Stenard F, Aoudjehane L, Miroux C, Podevin P, Morales O, Chouzenoux S, Scatton O, Groux H, Auriault C, Calmus Y, Pancre V, DelhemN. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant. 2009;9:2102-12.10.1111/j.1600-6143.2009.02743.x19624566
Search in Google Scholar Back to article
31. Wildbaum G, Netzer N, Karin N. Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest. 2002;110:701-1010.1172/JCI0215176
Search in Google Scholar Back to article
32. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22:633-42.10.1016/j.immuni.2005.03.01315894280
Search in Google Scholar Back to article
33. Eleftheriadis T, Pissas G, Karioti A, Antoniadi G, Liakopoulos V, Dafopoulou K, Pournaras S, Koukoulis G, Stefanidis I. The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes. Immunol Invest. 2012;41:507-20.10.3109/08820139.2012.68224422594922
Search in Google Scholar Back to article

Mesenchymal Stem Cells Attenuate Acute Liver Failure by Promoting Expansion of Regulatory T Cells in an Indoleamine 2,3-Dioxygenase-Dependent Manner

Abstract

Paradigm

My account